Cross-path reactive chromatography/mass spectrometry as a versatile platform for characterization of primary and higher order structure of complex heterogeneous proteins

交叉路径反应色谱/质谱作为多功能平台,用于表征复杂异质蛋白质的一级和高级结构

基本信息

  • 批准号:
    10350609
  • 负责人:
  • 金额:
    $ 30.94万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-03-01 至 2024-02-29
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY High-throughput characterization of increasingly complex and heterogeneous protein structures (including both primary and higher order structures) is now required in a variety of fields ranging from personalized medicine (biomarkers) to industrial-scale production of recombinant proteins (for both product quality control and feedback adaptive process control). However, extensive structural characterization usually involves several multi-step processes that are both time- and labor-consuming, and frequently cannot be implemented in a high-throughput format. Additional complication arises from the presence of multiple protein sub-populations in the analytical/clinical/production sample, which may exhibit altered functional or biophysical properties despite having very similar structural characteristics (e.g, small soluble aggregates, aberrant glycoforms, disulfide- scrambled species, etc.). The proposed research aims at developing a robust and versatile analytical technology using the novel cross-path reactive chromatography (XP-RC) platform with on-line detection by electrospray ionization mass spectrometry (ESI MS) augmented by protein ion manipulation in the gas phase (including both conventional top-down MS/MS and the limited charge reduction technique developed in our laboratory). XP-RC allows protein chemical modifications (such as disulfide reduction, covalent labeling, H/D exchange, etc.) to be combined in-line with the separation step and enables real-time MS measurements that are not adversely affected by components incompatible with the ESI process. This is achieved by utilizing the unique elution characteristics (retention) of proteins and small-molecule reagents in non-denaturing chromatographic media (size exclusion or ion exchange); during their retention the proteins can be exposed to various reagents to induce the desired modification(s) in a highly controlled fashion. Our preliminary data provide strong evidence that multiple reactions can be carried out inside a single column in a sequential manner by exposing the protein to multiple reagent plugs as it moves through the column prior to MS detection/characterization of the modified protein. The initial efforts will be focused on implementing differential in-line reduction of disulfide bonds followed by free thiol capping with isotopically labeled reagents for high-throughput disulfide mapping and glycoform profiling (Aim 1). These efforts will be then extended to enable selective reduction of inter-chain disulfides while preserving the non-covalent interactions and internal disulfides in complex protein systems to enable identification of binding partners within such systems; MS/MS detection will allow binding interfaces within such selectively preserved complexes to be localized (Aim 2). An alternative approach will utilize in-line chemical labeling as a means of localizing the binding interfaces. Lastly, the XP-RC/MS platform will be used to implement dilution-free H/D exchange characterization of protein complexes and small soluble aggregates in the top-down fashion (Aim 3).
项目摘要 日益复杂和异质蛋白结构的高通量表征(包括 现在需要在个性化医学的各个领域中进行初级和高级结构) (生物标志物)重组蛋白的工业规模生产(用于产品质量控制和反馈 自适应过程控制)。但是,广泛的结构表征通常涉及多个多步骤 时间和劳动力既耗费且经常在高通量中实施的过程 格式。其他并发症来自于在 分析/临床/生产样本,尽管 具有非常相似的结构特征(例如,小的可溶骨料,异常的糖型,二硫化物 - 炒种类等)。拟议的研究旨在开发强大而多功能的分析技术 使用新型的横向路线反应色谱(XP-RC)平台与电喷雾在线检测 电离质谱法(ESI MS)在气相中通过蛋白离子操纵增强(包括 常规的自上而下的MS/MS和我们实验室开发的有限电荷减少技术)。 XP-RC 允许蛋白质化学修饰(例如二硫键还原,共价标记,H/D交换等)为 与分离步骤结合在一起,并启用并非不利的实时MS测量 受ESI过程不相容的组件影响。这是通过利用独特的洗脱来实现的 在非塑性色谱介质中蛋白质和小分子试剂的特征(保留) (尺寸排除或离子交换);在保留期间,蛋白质可以暴露于各种试剂以诱导 以高度控制的方式进行了所需的修改。我们的初步数据提供了有力的证据表明 可以通过将蛋白质暴露于 多个试剂塞在MS检测/表征的MS检测/表征之前通过列移动。 蛋白质。最初的努力将集中于实施差异的二硫键在线减少。 通过与同位素标记的试剂的游离硫醇限额,用于高通量二硫化物和糖型 分析(目标1)。然后将扩展这些努力,以使选择性减少链间二硫化物的选择性 保留复杂蛋白质系统中的非共价相互作用和内部二硫化物以实现 在这种系统中识别约束伙伴; MS/MS检测将允许在此类中绑定接口 有选择地保留的要局部的复合物(AIM 2)。另一种方法将使用在线化学 标记作为定位结合界面的一种手段。最后,XP-RC/MS平台将用于实现 自上而下 时尚(目标3)。

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Mass spectrometry-based methods in characterization of the higher order structure of protein therapeutics
Charge Manipulation Using Solution and Gas-Phase Chemistry to Facilitate Analysis of Highly Heterogeneous Protein Complexes in Native Mass Spectrometry.
  • DOI:
    10.1021/acs.analchem.0c05249
  • 发表时间:
    2021-02-23
  • 期刊:
  • 影响因子:
    7.4
  • 作者:
    Yang Y;Niu C;Bobst CE;Kaltashov IA
  • 通讯作者:
    Kaltashov IA
Rapid Evaluation of the Extent of Haptoglobin Glycosylation Using Orthogonal Intact-Mass MS Approaches and Multivariate Analysis
  • DOI:
    10.1021/acs.analchem.1c05585
  • 发表时间:
    2022-03-29
  • 期刊:
  • 影响因子:
    7.4
  • 作者:
    Ivanov, Daniil G.;Yang, Yang;Kaltashov, Igor A.
  • 通讯作者:
    Kaltashov, Igor A.
Extending the capabilities of intact-mass analyses to monoclonal immunoglobulins of the E-isotype (IgE).
  • DOI:
    10.1080/19420862.2022.2103906
  • 发表时间:
    2022-01
  • 期刊:
  • 影响因子:
    5.3
  • 作者:
    Yang, Wenhua;Ivanov, Daniil G.;Kaltashov, Igor A.
  • 通讯作者:
    Kaltashov, Igor A.
共 4 条
  • 1
前往

IGOR A KALTASHOV的其他基金

An integrated mass spectrometry approach to study heparin structure-bioactivity
研究肝素结构-生物活性的综合质谱方法
  • 批准号:
    9252476
    9252476
  • 财政年份:
    2016
  • 资助金额:
    $ 30.94万
    $ 30.94万
  • 项目类别:
An integrated mass spectrometry approach to study heparin structure-bioactivity
研究肝素结构-生物活性的综合质谱方法
  • 批准号:
    10531619
    10531619
  • 财政年份:
    2016
  • 资助金额:
    $ 30.94万
    $ 30.94万
  • 项目类别:
An integrated mass spectrometry approach to study heparin structure-bioactivity
研究肝素结构-生物活性的综合质谱方法
  • 批准号:
    10322743
    10322743
  • 财政年份:
    2016
  • 资助金额:
    $ 30.94万
    $ 30.94万
  • 项目类别:
Investigation of protein dynamics by mass spectrometry
通过质谱研究蛋白质动力学
  • 批准号:
    7935574
    7935574
  • 财政年份:
    2009
  • 资助金额:
    $ 30.94万
    $ 30.94万
  • 项目类别:
ACQUISITION ELECTROSPRAY TOF MASS SPECTROMETER: PROTEIN STUDIES
采集电喷雾 TOF 质谱仪:蛋白质研究
  • 批准号:
    6973452
    6973452
  • 财政年份:
    2004
  • 资助金额:
    $ 30.94万
    $ 30.94万
  • 项目类别:
Acquisition of an electrospray TOF mass spectrometer
购置电喷雾 TOF 质谱仪
  • 批准号:
    6732556
    6732556
  • 财政年份:
    2004
  • 资助金额:
    $ 30.94万
    $ 30.94万
  • 项目类别:
PROTEIN FOLDING DYNAMICS BY MASS SPECTROMETRY
通过质谱分析蛋白质折叠动力学
  • 批准号:
    6387202
    6387202
  • 财政年份:
    2000
  • 资助金额:
    $ 30.94万
    $ 30.94万
  • 项目类别:
Investigations of interactions in dynamic protein complexes by mass spectrometry
通过质谱研究动态蛋白质复合物中的相互作用
  • 批准号:
    8310015
    8310015
  • 财政年份:
    2000
  • 资助金额:
    $ 30.94万
    $ 30.94万
  • 项目类别:
Investigation of protein dynamics by mass spectrometry
通过质谱研究蛋白质动力学
  • 批准号:
    7254052
    7254052
  • 财政年份:
    2000
  • 资助金额:
    $ 30.94万
    $ 30.94万
  • 项目类别:
PROTEIN FOLDING DYNAMICS BY MASS SPECTROMETRY
通过质谱分析蛋白质折叠动力学
  • 批准号:
    6520291
    6520291
  • 财政年份:
    2000
  • 资助金额:
    $ 30.94万
    $ 30.94万
  • 项目类别:

相似国自然基金

基于靶向代谢组学结合肽指纹谱非标记药物靶标分析新方法的紫草素抑制白念珠菌生物被膜作用机制研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于靶向代谢组学结合肽指纹谱非标记药物靶标分析新方法的紫草素抑制白念珠菌生物被膜作用机制研究
  • 批准号:
    82104127
  • 批准年份:
    2021
  • 资助金额:
    24.00 万元
  • 项目类别:
    青年科学基金项目
15N标记麻痹性贝类毒素在牡蛎中转化及壳聚糖衍生物脱毒机制
  • 批准号:
    31772089
  • 批准年份:
    2017
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目
新型非标记位点可控型功能DNA荧光传感器的开发及在环境检测和生物分析中的应用
  • 批准号:
    21775084
  • 批准年份:
    2017
  • 资助金额:
    65.0 万元
  • 项目类别:
    面上项目

相似海外基金

Impacts of Acute Ambient Air Pollution Exposure on Women's Reproductive Health: Identifying Mechanisms and Susceptible Reproductive Processes Across the Menstrual Cycle and Early Pregnancy
急性环境空气污染暴露对女性生殖健康的影响:确定月经周期和怀孕早期的机制和易受影响的生殖过程
  • 批准号:
    10645818
    10645818
  • 财政年份:
    2023
  • 资助金额:
    $ 30.94万
    $ 30.94万
  • 项目类别:
Inflammatory stressors in serotonergic brainstem dysfunction and SIDS
血清素能脑干功能障碍和 SIDS 中的炎症应激源
  • 批准号:
    10659327
    10659327
  • 财政年份:
    2023
  • 资助金额:
    $ 30.94万
    $ 30.94万
  • 项目类别:
Pilot Studies of PAX3-FOXO1 Fusions Proteins in Alveolar Rhabdomyosarcoma
PAX3-FOXO1 融合蛋白在肺泡横纹肌肉瘤中的初步研究
  • 批准号:
    10726763
    10726763
  • 财政年份:
    2023
  • 资助金额:
    $ 30.94万
    $ 30.94万
  • 项目类别:
Popliteal Pterygium syndrome, IRf6, and the periderm
腘胬肉综合征、IRf6 和周皮
  • 批准号:
    10727050
    10727050
  • 财政年份:
    2023
  • 资助金额:
    $ 30.94万
    $ 30.94万
  • 项目类别:
Targeting neuronal transport to ameliorate vincristine neurotoxicity
靶向神经元运输以改善长春新碱神经毒性
  • 批准号:
    10736789
    10736789
  • 财政年份:
    2023
  • 资助金额:
    $ 30.94万
    $ 30.94万
  • 项目类别: